1 | Cancer | 1.6% | |
2 | Study | 1.6% | |
3 | Pain | 1.6% | |
4 | Risk | 0.8% | |
5 | Doubling | 0.8% | |
6 | Genome | 0.8% | |
7 | Syndrome | 0.8% | |
8 | Tumors | 0.8% | |
9 | Metastatic | 0.8% | |
10 | AI | 0.8% | |
11 | Practice | 0.8% | |
12 | Blood | 0.8% | |
13 | Brain | 0.8% | |
14 | Total | 0.8% | |
15 | UK | 0.8% | |
16 | Genetic | 0.8% | |
17 | Immunotherapy | 0.8% | |
18 | HIV | 0.8% | |
19 | Use | 0.8% | |
20 | Reduce | 0.4% | |
21 | Canine | 0.4% | |
22 | Women’s | 0.4% | |
23 | Clinical | 0.4% | |
24 | Chatbot | 0.4% | |
25 | Gut | 0.4% | |
26 | Cryotherapy | 0.4% | |
27 | Allergy | 0.4% | |
28 | $1B | 0.4% | |
29 | Added | 0.4% | |
30 | Cefazolin | 0.4% | |
31 | Doubled | 0.4% | |
32 | Mechanical | 0.4% | |
33 | Proteins | 0.4% | |
34 | Acid | 0.4% | |
35 | Vaccine | 0.4% | |
36 | Menopause | 0.4% | |
37 | Africa’s | 0.4% | |
38 | Late-Line | 0.4% | |
39 | Drug | 0.4% | |
40 | Fibrosis | 0.4% | |
41 | Age | 0.4% | |
42 | Emphysema | 0.4% | |
43 | Fight | 0.4% | |
44 | mCRPC | 0.4% | |
45 | Overlapping | 0.4% | |
46 | High | 0.4% | |
47 | Atypical | 0.4% | |
48 | Complexity | 0.4% | |
49 | Pneumonia | 0.4% | |
50 | Pharmacogenomics | 0.4% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|